ATH alterity therapeutics limited

Stock price - ATH/ATHE, page-1228

  1. 39 Posts.
    lightbulb Created with Sketch. 5
    Would Stamler do everything within his power and influence to avoid a takeover.
    Another biotech I own is led by a CEO (also Chairman of BOD - so, poor/no governance) who has refused to sell, much less partner with BP and give up royalties. SP has lost 80% of value this year, and 99.8% of value since he assumed Board Chair in 2002. His gravy train has kept plugging along, though. Hired unqualified family members, etc. I know Stamler not that type of CEO, but is he motivated to maximize shareholder value over his personal ambitions? The CR made me wonder...
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.3¢
Change
-0.001(7.14%)
Mkt cap ! $119.6M
Open High Low Value Volume
1.4¢ 1.5¢ 1.3¢ $123.8K 8.854M

Buyers (Bids)

No. Vol. Price($)
36 22048002 1.3¢
 

Sellers (Offers)

Price($) Vol. No.
1.4¢ 980000 4
View Market Depth
Last trade - 16.10pm 07/08/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.